In a randomized controlled trial, 87 pregnant women with GDM or type 2 diabetes mellitus (T2DM) received insulin detemir (n=42) or NPH (n=45), with short-acting insulin aspart as needed. Here, INS is linked to type 2 diabetes mellitus.